Found: 2
Select item for more details and to access through your institution.
A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 367, doi. 10.1007/s00262-003-0376-9
- By:
- Publication type:
- Article
Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0231892
- By:
- Publication type:
- Article